• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)(520500.SH)

Last Updated 00:00:00
longbridge loading
Overview
News
Holdings
Company Encyclopedia
View More
name
Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)
520500.SH
Shareholder
Ownership%OwnedShare ChgReport Date
No Data
News
View More

Ant Group upgrades AI health service AQ's PC platform with DeepSearch for evidence-based clinical decision support, available free to clinicians.

Ant Group has enhanced its AI health assistant, AQ, on its PC platform by introducing DeepSearch, a feature designed to support evidence-based clinical decision-making. This upgrade is available for free to clinicians and medical students, offering functionalities such as Health Q&A and medical literature searches. This initiative reflects Ant Group's dedication to aiding healthcare professionals in their decision-making processes.

Unusual Whales·10 Hours ago
Unusual Whales·10 Hours ago
© 2026 Longbridge|Disclaimer

Event Tracking

Jan21
Huitianfu Fund Management Co. Reduced ST Pharm to 1.7845 million shares
11:05
Merck & Moderna Disclose mRNA Cancer Vaccine Five-Year Clinical Data
07:52
Jan19
China Biopharmaceutical Acquires Herjia for 120 Million
10:00
WuXi Biologics and WuXi ChemPartner to Acquire at Least 60% of Tonox
06:52
BofA Securities Initiates Coverage of CanSino Biologics with a Buy Rating
01:48
Jan16
CITIC Fund Management Co., Ltd.增持三生制药
11:21